Device Firms Cheer ICD-10 Debut, While Providers Brace For Chaos
This article was originally published in The Gray Sheet
Executive Summary
The ICD-10 health care coding set has finally launched after much debate and delay. Medical device manufacturers cheer the transition as a means to better capture new technology in the insurance system, but health care providers are bracing for technical headaches and the risk of claims not being paid.
You may also be interested in...
Reimbursement Briefs: AMA Wants ICD-10 Halt; News From CMS, AHRQ And OIG
AMA asks CMS to reconsider ICD-10 implementation. CMS explores specialist payment models. AHRQ quality measures clearinghouse endorses new Medicare hip and knee replacement measures tied to readmissions and complications. More reimbursement news.
Costs Are Central To Arguments For And Against Accelerated ICD-10 Adoption
Device firms and others who support accelerated adoption of a greatly expanded health care billing code system, and payers who warn against moving too fast, each are invoking hot-button economic and health reform issues to make their case
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.